Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 2
1948 2
1949 1
1953 1
1954 1
1955 3
1957 1
1958 1
1959 1
1962 1
1964 3
1965 1
1970 1
1974 1
1975 12
1976 12
1977 16
1978 29
1979 14
1980 19
1981 33
1982 27
1983 22
1984 26
1985 19
1986 13
1987 20
1988 12
1989 16
1990 16
1991 19
1992 27
1993 26
1994 30
1995 22
1996 34
1997 41
1998 39
1999 37
2000 31
2001 42
2002 44
2003 43
2004 46
2005 47
2006 54
2007 65
2008 57
2009 64
2010 79
2011 70
2012 92
2013 88
2014 71
2015 88
2016 88
2017 60
2018 72
2019 79
2020 77
2021 74
2022 85
2023 51
2024 67

Text availability

Article attribute

Article type

Publication date

Search Results

2,044 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrating Cabotegravir + Rilpivirine Long-Acting Into European Clinical Settings.
Jonsson-Oldenbüttel C, Ghosn J, van der Valk M, Florence E, Vera F, De Wit S, Rami A, Bonnet F, Hocqueloux L, Hove K, Ait-Khaled M, DeMoor R, Bontempo G, Latham CL, Gutner CA, Iyer S, Gill M, Czarnogorski M, D'Amico R, van Wyk J. Jonsson-Oldenbüttel C, et al. J Acquir Immune Defic Syndr. 2024 Aug 15;96(5):472-480. doi: 10.1097/QAI.0000000000003448. Epub 2024 Jul 9. J Acquir Immune Defic Syndr. 2024. PMID: 38985445 Free PMC article. Clinical Trial.
Implementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.
Gutner CA, Hocqueloux L, Jonsson-Oldenbüttel C, Vandekerckhove L, van Welzen BJ, Slama L, Crusells-Canales M, Sierra JO, DeMoor R, Scherzer J, Ait-Khaled M, Bontempo G, Gill M, Patel N, D'Amico R, Hove K, Baugh B, Barnes N, Hadi M, Low EL, Anand SB, Hamilton A, Garges HP, Czarnogorski M. Gutner CA, et al. J Int AIDS Soc. 2024 Jul;27(7):e26243. doi: 10.1002/jia2.26243. J Int AIDS Soc. 2024. PMID: 38978405 Free PMC article. Clinical Trial.
2,044 results
-